Researchers are excited about this new drug, a novel dual compound showing significant data in initial trials for body management. It acts by modulating two pathways : GLP-1 and GIP, that , when stimulated, support influence appetite and enhance energy expenditure . Initial observations indicate considerable weight loss and possible advantages for